PL2437736T3 - Systemy dostarczania leków - Google Patents
Systemy dostarczania lekówInfo
- Publication number
- PL2437736T3 PL2437736T3 PL10730357T PL10730357T PL2437736T3 PL 2437736 T3 PL2437736 T3 PL 2437736T3 PL 10730357 T PL10730357 T PL 10730357T PL 10730357 T PL10730357 T PL 10730357T PL 2437736 T3 PL2437736 T3 PL 2437736T3
- Authority
- PL
- Poland
- Prior art keywords
- drug delivery
- delivery systems
- systems
- drug
- delivery
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues
- C12N5/0602—Vertebrate cells
- C12N5/0634—Cells from the blood or the immune system
- C12N5/0641—Erythrocytes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K35/14—Blood; Artificial blood
- A61K35/18—Erythrocytes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- A61K38/12—Cyclic peptides, e.g. bacitracins; Polymyxins; Gramicidins S, C; Tyrocidins A, B or C
- A61K38/13—Cyclosporins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/42—Proteins; Polypeptides; Degradation products thereof; Derivatives thereof, e.g. albumin, gelatin or zein
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/69—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit
- A61K47/6901—Conjugates being cells, cell fragments, viruses, ghosts, red blood cells or viral vectors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P39/00—General protective or antinoxious agents
- A61P39/02—Antidotes
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S424/00—Drug, bio-affecting and body treating compositions
- Y10S424/81—Drug, bio-affecting and body treating compositions involving autoimmunity, allergy, immediate hypersensitivity, delayed hypersensitivity, immunosuppression, immunotolerance, or anergy
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB0909754.4A GB0909754D0 (en) | 2009-06-05 | 2009-06-05 | Drug delivery systems |
PCT/EP2010/003783 WO2010145849A2 (en) | 2009-06-05 | 2010-06-07 | Drug delivery systems |
EP10730357.0A EP2437736B1 (en) | 2009-06-05 | 2010-06-07 | Drug delivery systems |
Publications (1)
Publication Number | Publication Date |
---|---|
PL2437736T3 true PL2437736T3 (pl) | 2018-01-31 |
Family
ID=40937008
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PL10730357T PL2437736T3 (pl) | 2009-06-05 | 2010-06-07 | Systemy dostarczania leków |
Country Status (11)
Country | Link |
---|---|
US (1) | US8734787B2 (pl) |
EP (1) | EP2437736B1 (pl) |
AU (1) | AU2010262090B2 (pl) |
CA (1) | CA2763695C (pl) |
DK (1) | DK2437736T3 (pl) |
ES (1) | ES2645775T3 (pl) |
GB (1) | GB0909754D0 (pl) |
NO (1) | NO2437736T3 (pl) |
NZ (1) | NZ596813A (pl) |
PL (1) | PL2437736T3 (pl) |
WO (1) | WO2010145849A2 (pl) |
Families Citing this family (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2011051346A1 (en) * | 2009-10-27 | 2011-05-05 | Erytech Pharma | Composition to induce specific immune tolerance |
ITBO20100256A1 (it) * | 2010-04-26 | 2011-10-27 | Erydel Spa | Metodo per incapsulare almeno un composto ad uso terapeutico e/o diagnostico all'interno di eritrociti |
BR112014009346B1 (pt) | 2011-10-17 | 2020-09-15 | Massachusetts Institute Of Technology | Entrega intracelular |
ES2865107T3 (es) | 2013-08-16 | 2021-10-15 | Massachusetts Inst Technology | Administración selectiva de material a células |
KR20230098928A (ko) | 2014-10-31 | 2023-07-04 | 메사추세츠 인스티튜트 오브 테크놀로지 | 면역 세포로의 생체분자의 전달 |
JP6846345B2 (ja) | 2014-11-14 | 2021-03-24 | マサチューセッツ インスティテュート オブ テクノロジー | 破壊及び場による細胞への化合物及び組成物の送達 |
CN107250373A (zh) | 2015-01-12 | 2017-10-13 | 麻省理工学院 | 通过微流体递送实现的基因编辑 |
WO2017008063A1 (en) | 2015-07-09 | 2017-01-12 | Massachusetts Institute Of Technology | Delivery of materials to anucleate cells |
WO2017041051A1 (en) | 2015-09-04 | 2017-03-09 | Sqz Biotechnologies Company | Intracellular delivery of biomolecules to cells comprising a cell wall |
US11123441B2 (en) | 2016-10-04 | 2021-09-21 | The Trustees Of The University Of Pennsylvania | Methods and compositions for drug delivery |
Family Cites Families (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FI111730B (fi) * | 1990-11-02 | 2003-09-15 | Novartis Ag | Menetelmä ei-immunosuppressiivisen syklosporiinin valmistamiseksi |
US5482945A (en) * | 1992-12-22 | 1996-01-09 | American Home Products Corporation | Innovative technique for immunosuppression involving administration of rapamycin loaded formed blood elements |
AU7843394A (en) * | 1993-10-27 | 1995-05-22 | Regents Of The University Of California, The | Antiviral compounds |
DE69732225T2 (de) | 1997-05-05 | 2005-06-23 | Dideco S.R.L., Mirandola | Verfahren zur Verkapselung von biologisch aktiven Stoffen in Erythrocyten und Gerät dafür |
US6887842B1 (en) * | 1999-11-19 | 2005-05-03 | The Board Of Trustees Of The Leland Stanford Junior University | Modulating a pharmacokinetic property of a drug by administering a bifunctional molecule containing the drug |
WO2003073993A2 (en) * | 2002-03-01 | 2003-09-12 | Colb Mark A | Binding of red blood cell to exposed subendothelial surfaces to impede platelet deposition thereon and/or for use in targeted drug delivery thereto |
US7465298B2 (en) * | 2002-06-28 | 2008-12-16 | Mercator Medsystems, Inc. | Methods and systems for delivering liquid substances to tissues surrounding body lumens |
GB2439747A (en) | 2006-07-03 | 2008-01-09 | Uni Degli Studi Di Urbino Carl | Delivery of contrasting agents for magnetic resonance imaging |
US20090053245A1 (en) * | 2007-05-29 | 2009-02-26 | Mutz Mitchell W | Pharmacokinetics and Efficacy of Anti-Angiogenic Drugs and Drugs Treating Diseases of the Blood |
-
2009
- 2009-06-05 GB GBGB0909754.4A patent/GB0909754D0/en not_active Ceased
-
2010
- 2010-06-07 PL PL10730357T patent/PL2437736T3/pl unknown
- 2010-06-07 NZ NZ596813A patent/NZ596813A/en unknown
- 2010-06-07 ES ES10730357.0T patent/ES2645775T3/es active Active
- 2010-06-07 NO NO10730357A patent/NO2437736T3/no unknown
- 2010-06-07 CA CA2763695A patent/CA2763695C/en active Active
- 2010-06-07 DK DK10730357.0T patent/DK2437736T3/da active
- 2010-06-07 EP EP10730357.0A patent/EP2437736B1/en active Active
- 2010-06-07 US US13/375,890 patent/US8734787B2/en active Active
- 2010-06-07 AU AU2010262090A patent/AU2010262090B2/en active Active
- 2010-06-07 WO PCT/EP2010/003783 patent/WO2010145849A2/en active Application Filing
Also Published As
Publication number | Publication date |
---|---|
NZ596813A (en) | 2013-12-20 |
WO2010145849A3 (en) | 2011-12-15 |
EP2437736A2 (en) | 2012-04-11 |
DK2437736T3 (da) | 2017-11-13 |
US20120141540A1 (en) | 2012-06-07 |
CA2763695A1 (en) | 2010-12-23 |
AU2010262090B2 (en) | 2016-08-25 |
CA2763695C (en) | 2016-09-13 |
WO2010145849A2 (en) | 2010-12-23 |
AU2010262090A1 (en) | 2011-12-15 |
ES2645775T3 (es) | 2017-12-07 |
US8734787B2 (en) | 2014-05-27 |
NO2437736T3 (pl) | 2017-12-30 |
GB0909754D0 (en) | 2009-07-22 |
EP2437736B1 (en) | 2017-08-02 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HK1258442A1 (zh) | 藥劑遞送系統 | |
HK1201223A1 (en) | Drug delivery management systems | |
PL2398500T3 (pl) | System dostarczania leków na bazie glutationu | |
ZA201101737B (en) | Progestin-containing drug delivery system | |
PL2654864T3 (pl) | System dostarczania leku | |
HK1166731A1 (en) | Drug delivery device | |
HK1164759A1 (en) | Medicament delivery devices | |
HK1164758A1 (en) | Medicament delivery devices | |
HK1164176A1 (en) | Medicament delivery devices | |
EP2516671A4 (en) | SYSTEMS FOR MANAGING DRUG DELIVERY DEVICES | |
GB0903810D0 (en) | Delivery system | |
IL215219A0 (en) | Drug delivery device | |
IL218839A0 (en) | Drug delivery device | |
PL2401027T3 (pl) | Układ do interwencyjnego dostarczania leku | |
EP2481399A4 (en) | ACTIVE COMPOSITION SYSTEM WITH LONG-TERM EFFECT | |
EP2382947A4 (en) | STENT DELIVERY SYSTEM | |
IL214099A0 (en) | Conjugate based systems for controlled drug delivery | |
HK1166728A1 (en) | Drug delivery device | |
EP2431009A4 (en) | STENT LAYING SYSTEM | |
ZA201106668B (en) | Zoo-technical drug delivery device | |
PL2506909T3 (pl) | Urządzenie do podawania leków | |
PL2437736T3 (pl) | Systemy dostarczania leków | |
IL217416A0 (en) | Drug delivery delivery device | |
GB201006818D0 (en) | Drug delivery | |
GB201018750D0 (en) | Drug delivery system |